Aihua Tan
Overview
Explore the profile of Aihua Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1854
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu S, Chen H, Tan A, Yang H, Tong J
J Neurochem
. 2025 Mar;
169(3):e70043.
PMID: 40066934
Patients are usually highly stressed during the immediate perioperative period. It remains unclear whether increased stress contributes to postoperative brain dysfunction. Here, the clinical perioperative setting was mimicked via exploratory...
2.
Li J, Tang Y, Chen Q, Lei S, Lu Y, Tan A, et al.
Medicine (Baltimore)
. 2025 Feb;
103(52):e41082.
PMID: 39969377
For patients with human epidermal growth factor receptor 2 (HER2)-low advanced breast cancer who had failed to meet with anthracycline or taxane, the application of HER2-targeted antibody-drug conjugates as second-line...
3.
Tan A, Yang S, Pan Y, Lin Q
Arch Med Sci
. 2024 Dec;
20(5):1710-1714.
PMID: 39649261
No abstract available.
4.
Wu M, Lei S, Tang Y, He C, Zhang J, Lu X, et al.
Clin Breast Cancer
. 2024 Nov;
PMID: 39603902
Objective: This study was designed to investigate the efficacy and safety of pyrotinib-based therapy for HER2-positive breast cancer with brain metastases (BM) in the real-world setting. Methods: Data of HER2-positive...
5.
Lu H, Tan A, Zhang Y, Chen Y, Ran S, Wang P
J Ethnopharmacol
. 2024 Feb;
328:117993.
PMID: 38423408
Ethnopharmacological Relevance: Alzheimer's disease (AD) is a multi-factorial degenerative disease, and multi-targeted therapies targeting multiple pathogenic mechanisms should be explored. Shenghui decoction (SHD) is an ancient traditional Chinese medicine (TCM)...
6.
Tan A, Nong L, Wang H, Jia Y, Zhong W, Qin F, et al.
Cancer Biol Ther
. 2023 Oct;
24(1):2265055.
PMID: 37831547
Purpose: Apatinib is a tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor (VEGFR)-2. This study was conducted to assess the efficacy and safety of apatinib combined with exemestane in...
7.
Pei X, Yao J, Ran S, Lu H, Yang S, Zhang Y, et al.
Front Endocrinol (Lausanne)
. 2023 May;
14:1167317.
PMID: 37251666
Introduction: Existing evidence suggests an association between certain vitamins and metabolic syndrome (MetS), but few epidemiological studies have focused on the effects of multivitamin co-exposure on MetS. This study aims...
8.
Wei Y, Wei H, Wei Y, Tan A, Chen X, Liao X, et al.
Front Oncol
. 2022 Mar;
12:820883.
PMID: 35265522
Objective: Human endogenous retroviruses (HERVs) make up 8% of the human genome. HERVs are biologically active elements related to multiple diseases. HERV-K, a subfamily of HERVs, has been associated with...
9.
Pan L, Li L, Peng H, Fan L, Liao J, Wang M, et al.
J Affect Disord
. 2022 Feb;
303:52-57.
PMID: 35124113
Objective: This study aimed to explore the potential effect of sleep time, pain and life satisfaction on the association between marital status and depressive symptoms. Methods: This study included 9780...
10.
Tan A, Wang H, Nong L, Jia Y, Liu Y, Zhong W, et al.
Ann Palliat Med
. 2022 Jan;
10(12):12101-12112.
PMID: 35016411
Background: This study aimed to prospectively evaluate and investigate the efficacy and safety of recombinant human endostatin (Rh-endostatin) combined with platinum-based regimens for advanced triple-negative breast cancer (TNBC) patients. Methods:...